Literature DB >> 17878375

Analysis of eosinophil turnover in vivo reveals their active recruitment to and prolonged survival in the peritoneal cavity.

Caspar Ohnmacht1, Andrea Pullner, Nico van Rooijen, David Voehringer.   

Abstract

Eosinophils are potent effector cells associated with allergic inflammation and parasite infections. However, limited information exists about their turnover, migration, and survival in vivo. To address these important questions, we determined murine eosinophil turnover under steady state and inflammatory conditions by flow cytometric analysis of BrdU incorporation and analyzed their migration pattern and survival in different tissues after adoptive transfer into recipient mice. In naive mice approximately 50% of bone marrow eosinophils were labeled with BrdU during a 15-h pulse, whereas only 10% of splenic eosinophils were labeled within this time frame. Unexpectedly, the rate of eosinophil production did not change during acute infection with the helminth parasite Nippostrongylus brasiliensis despite massive eosinophilia in several tissues. Eosinophils present in lung and peritoneum remained largely BrdU negative, indicating that eosinophilia in end organs was mainly caused by increased survival of already existing eosinophils rather than increased production of new eosinophils in the bone marrow. Adoptive transfer experiments revealed that eosinophils preferentially migrated to the peritoneum in a macrophage-independent and pertussis toxin-sensitive manner, where they survived for several days. Peritoneal eosinophils expressed high levels of the inhibitory receptor Siglec-F, released less eosinophil peroxidase compared with eosinophils from the spleen, and could recirculate to other organs. These results demonstrate that the peritoneum serves as reservoir for eosinophils.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17878375     DOI: 10.4049/jimmunol.179.7.4766

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  Dusp5 negatively regulates IL-33-mediated eosinophil survival and function.

Authors:  Derek A Holmes; Jung-Hua Yeh; Donghong Yan; Min Xu; Andrew C Chan
Journal:  EMBO J       Date:  2014-11-14       Impact factor: 11.598

2.  Eosinophils in the zebrafish: prospective isolation, characterization, and eosinophilia induction by helminth determinants.

Authors:  Keir M Balla; Geanncarlo Lugo-Villarino; Jan M Spitsbergen; David L Stachura; Yan Hu; Karina Bañuelos; Octavio Romo-Fewell; Raffi V Aroian; David Traver
Journal:  Blood       Date:  2010-08-16       Impact factor: 22.113

3.  Toward the Proteome of the Human Peripheral Blood Eosinophil.

Authors:  Christof Straub; Konrad Pazdrak; Travis W Young; Susan J Stafford; Zheng Wu; John E Wiktorowicz; Anthony M Haag; Robert D English; Kizhake V Soman; Alexander Kurosky
Journal:  Proteomics Clin Appl       Date:  2009       Impact factor: 3.494

Review 4.  Here, There, and Anywhere? Arguments for and against the Physical Plasma Cell Survival Niche.

Authors:  Joel R Wilmore; David Allman
Journal:  J Immunol       Date:  2017-08-01       Impact factor: 5.422

Review 5.  Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors.

Authors:  B S Bochner
Journal:  Clin Exp Allergy       Date:  2009-03       Impact factor: 5.018

Review 6.  Basic and clinical immunology of Siglecs.

Authors:  Stephan von Gunten; Bruce S Bochner
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

7.  Altered eosinophil profile in mice with ST6Gal-1 deficiency: an additional role for ST6Gal-1 generated by the P1 promoter in regulating allergic inflammation.

Authors:  Mehrab Nasirikenari; E V Chandrasekaran; Khushi L Matta; Brahm H Segal; Paul N Bogner; Amit A Lugade; Yasmin Thanavala; James J Lee; Joseph T Y Lau
Journal:  J Leukoc Biol       Date:  2009-12-09       Impact factor: 4.962

8.  Eosinophil adoptive transfer system to directly evaluate pulmonary eosinophil trafficking in vivo.

Authors:  Ting Wen; John A Besse; Melissa K Mingler; Patricia C Fulkerson; Marc E Rothenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-27       Impact factor: 11.205

9.  Chemotaxis of bone marrow derived eosinophils in vivo: a novel method to explore receptor-dependent trafficking in the mouse.

Authors:  Eva M Sturm; Kimberly D Dyer; Caroline M Percopo; Akos Heinemann; Helene F Rosenberg
Journal:  Eur J Immunol       Date:  2013-06-14       Impact factor: 5.532

Review 10.  Eosinophils and allergic airway disease: there is more to the story.

Authors:  Elizabeth R Walsh; Avery August
Journal:  Trends Immunol       Date:  2009-11-18       Impact factor: 16.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.